In this month’s From the Editor’s Desk, Dr. Schapira reflects on this year’s Advance of the Year and what it says about cancer research more broadly. Read More
Blog
February 11, 2019 Greg Guthrie, ASCO Staff
The 2019 Genitourinary Cancers Symposium will feature new research on treatments for prostate cancer and kidney cancer. Read More
February 7, 2019 Abhishek Kumar, MD
If you’ve been diagnosed with a gynecologic cancer, learning about your disease and its treatment can help you make well-informed decisions and regain a sense of control. Read More
February 5, 2019 Florence Kurttila, MS
Survivor and advocate Florence Kurttila describes her key takeaways from the 2019 Gastrointestinal Cancers Symposium. Read More
January 31, 2019 Greg Guthrie, ASCO Staff
In 2019, ASCO recognizes the progress in treating rare cancers as the Advance of the Year. Impressive progress has been made in bringing new treatment advances to cancers that are rare and difficult to treat. This year’s Clinical Cancer Advances report describes emerging treatments for thyroid cancer, uterine cancer, desmoid tumor, neuroendocrine tumor, and tenosynovial giant cell tumor. Read More